PRESS RELEASE published on 03/26/2026 at 21:15, 2 months 22 days ago NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 Nanobiotix to announce fourth quarter and full year 2025 operational and financial update on March 31, 2026. Conference call and webcast scheduled for April 1, 2026 Conference Call Webcast Financial Update NANOBIOTIX Late-clinical Stage Biotechnology
BRIEF published on 03/25/2026 at 15:16, 2 months 23 days ago NANOBIOTIX denies takeover rumors Biotechnology Takeover NANOBIOTIX Rumors Nanoparticles
BRIEF published on 03/25/2026 at 15:16, 2 months 23 days ago NANOBIOTIX Responds to Media Speculation on Takeover Intentions Biotechnology Nanotechnology Takeover Speculation NANOBIOTIX Public Statement
PRESS RELEASE published on 03/25/2026 at 15:11, 2 months 23 days ago NANOBIOTIX Statement Regarding Recent Media Speculation Nanobiotix issues statement addressing media speculation on public take-over intentions, denying any such plans and highlighting factual inaccuracies in recent reports Media Speculation Statement NANOBIOTIX Public Take-over Factual Inaccuracies
BRIEF published on 03/12/2026 at 21:20, 3 months 5 days ago Nanobiotix Announces Voting Rights and Share Capital Details Euronext Paris Share Capital Voting Rights Nasdaq NANOBIOTIX
PRESS RELEASE published on 03/12/2026 at 21:15, 3 months 5 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital details as of February 28, 2026, on Euronext Paris and Nasdaq markets. Learn about their disruptive therapeutic approaches and global presence Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/25/2026 at 22:20, 3 months 20 days ago NANOBIOTIX Presents at Key Conferences in March Biotechnology Investor Conferences Cancer Treatments NANOBIOTIX Clinical Advances
BRIEF published on 02/17/2026 at 22:20, 4 months ago Nanobiotix Announces Updated Voting Rights and Share Capital Euronext Paris Voting Rights Shares Capital Financial Disclosure NANOBIOTIX
PRESS RELEASE published on 02/17/2026 at 22:15, 4 months ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital. The biotech company is listed on Euronext Paris and Nasdaq, focusing on disruptive therapies Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/02/2026 at 09:44, 4 months 15 days ago Goldman Sachs reduces its stake in Nanobiotix Euronext Paris Goldman Sachs Threshold Crossing Transfer Of Shares NANOBIOTIX
Published on 06/17/2026 at 22:30, 27 minutes ago Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 6 hours 2 minutes ago Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/17/2026 at 16:45, 6 hours 12 minutes ago Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean
Published on 06/17/2026 at 14:30, 8 hours 27 minutes ago Solitario Advances 2026 Ponderosa Drilling Program
Published on 06/17/2026 at 14:00, 8 hours 57 minutes ago CHAR Tech Reminds Shareholders of June 18 Investor Update Call
Published on 06/17/2026 at 21:40, 1 hour 17 minutes ago Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon
Published on 06/17/2026 at 19:10, 3 hours 47 minutes ago Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa
Published on 06/17/2026 at 18:40, 4 hours 17 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/17/2026 at 18:36, 4 hours 21 minutes ago BILENDI: Bilendi announces that Euroland Corporate has initiated coverage of its shares
Published on 06/17/2026 at 18:23, 4 hours 34 minutes ago EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Conclusion of a delisting agreement with Bayerische Gewerbebau AG
Published on 06/17/2026 at 17:40, 5 hours 17 minutes ago Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 14 hours 12 minutes ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 11 hours ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 1 day 23 hours ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 3 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026
